Amylin-induced central IL-6 production enhances ventromedial hypothalamic leptin signaling

Diabetes

Volumn 64, Issue 5, 2015, Pages 1621-1631

  Foll, Christelle Le ^a   Johnson, Miranda D ^a,b   Dunn Meynell, Ambrose A ^c   Boyle, Christina N ^d,e   Lutz, Thomas A ^d,e,f   Levin, Barry E ^a,c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

^f Inst of Laboratory Animal Science   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGRP PROTEIN; AMYLIN; AMYLIN RECEPTOR; CILIARY NEUROTROPHIC FACTOR; CTR1A; CTR1B; GLYCOPROTEIN GP 130; IMMUNOGLOBULIN G; INSR PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; LEPR B PROTEIN; LEPTIN; LEPTIN RECEPTOR; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; NUCLEAR FACTOR Y; POMC PROTEIN; PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; STAT3 PROTEIN, MOUSE; STAT3 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FOOD INTAKE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IN VITRO STUDY; MALE; MICROGLIA; MOUSE; NERVE CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SENSITIZATION; SIGNAL TRANSDUCTION; WEIGHT GAIN; WEIGHT REDUCTION; ZONA INCERTA; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ASTROCYTES; GENE EXPRESSION REGULATION; INTERLEUKIN-6; ISLET AMYLOID POLYPEPTIDE; LEPTIN; MALE; MICE; MICE, KNOCKOUT; MICROGLIA; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 84931097462     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0645     Document Type: Article

References (50)

1. Ogawa A, Harris V, McCorkle SK, Unger RH, Luskey KL. Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment. J Clin Invest 1990;85:973-976.
2. Bao Y, Qin L, Kim E, et al. CD36 is involved in astrocyte activation and astroglial scar formation. J Cereb Blood Flow Metab 2012;32:1567-1577.
3. Heinrich G, Meece K, Wardlaw SL, Accili D. Preserved energy balance in mice lacking FoxO1 in neurons of Nkx2.1 lineage reveals functional heterogeneity of FoxO1 signaling within the hypothalamus. Diabetes 2014;63:1572-1582.
4. Roth JD. Amylin and the regulation of appetite and adiposity: Recent advances in receptor signaling, neurobiology and pharmacology. Curr Opin Endocrinol Diabetes Obes 2013;20:8-13.
5. Qi T, Ly K, Poyner DR, Christopoulos G, Sexton PM, Hay DL. Structurefunction analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors. Peptides 2011;32:1060-1067.
6. Bouret SG. Organizational actions of metabolic hormones. Front Neuroendocrinol 2013;34:18-26.
7. McLatchie LM, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998;393:333-339.
8. Born W, Fischer JA, Muff R. Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: The contributions of novel receptor- Activitymodifying proteins. Receptors Channels 2002;8:201-209.
9. Kuestner RE, Elrod RD, Grant FJ, et al. Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol Pharmacol 1994;46: 246-255.
10. Lutz TA. The role of amylin in the control of energy homeostasis. Am J Physiol Regul Integr Comp Physiol 2010;298:R1475-R1484.
11. Lutz TA. Effects of amylin on eating and adiposity. Handb Exp Pharmacol 2012;(209):231-250.
12. Paxinos G, Chai SY, Christopoulos G, et al. In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain. J Chem Neuroanat 2004;27:217-236.
13. Beaumont K, Kenney MA, Young AA, Rink TJ. High affinity amylin binding sites in rat brain. Mol Pharmacol 1993;44:493-497.
14. Hilton JM, Chai SY, Sexton PM. In vitro autoradiographic localization of the calcitonin receptor isoforms, C1a and C1b, in rat brain. Neuroscience 1995;69: 1223-1237.
15. Lutz TA, Senn M, Althaus J, Del Prete E, Ehrensperger F, Scharrer E. Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats. Peptides 1998;19:309-317.
16. Mollet A, Gilg S, Riediger T, Lutz TA. Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats. Physiol Behav 2004;81: 149-155.
17. Potes CS, Lutz TA. Brainstem mechanisms of amylin-induced anorexia. Physiol Behav 2010;100:511-518.
18. Mietlicki-Baase EG, Rupprecht LE, Olivos DR, et al. Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake. Neuropsychopharmacology 2013;38:1685-1697.
19. Roth JD, Roland BL, Cole RL, et al. Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies. Proc Natl Acad Sci U S A 2008;105:7257-7262.
20. Turek VF, Trevaskis JL, Levin BE, et al. Mechanisms of amylin/leptin synergy in rodent models. Endocrinology 2010;151:143-152.
21. Trevaskis JL, Coffey T, Cole R, et al. Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms. Endocrinology 2008;149:5679-5687.
22. Trevaskis JL, Lei C, Koda JE, Weyer C, Parkes DG, Roth JD. Interaction of leptin and amylin in the long- Term maintenance of weight loss in diet-induced obese rats. Obesity (Silver Spring) 2010;18:21-26.
23. Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-1271.
24. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffel M, Friedman JM. Leptin activation of Stat3 in the hypothalamus of wild- Type and ob/ob mice but not db/db mice. Nat Genet 1996;14:95-97.
25. Wallenius V, Wallenius K, Ahrén B, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002;8:75-79.
26. Flores MB, Fernandes MF, Ropelle ER, et al. Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats. Diabetes 2006;55:2554-2561.
27. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York, Academic Press, 1986.
28. Le Foll C, Dunn-Meynell A, Musatov S, Magnan C, Levin BE. FAT/CD36: A major regulator of neuronal fatty acid sensing and energy homeostasis in rats and mice. Diabetes 2013;62:2709-2716.
29. Le Foll C, Irani BG, Magnan C, Dunn-Meynell AA, Levin BE. Characteristics and mechanisms of hypothalamic neuronal fatty acid sensing. Am J Physiol Regul Integr Comp Physiol 2009;297:R655-R664.
30. Le Foll C, Dunn-Meynell AA, Miziorko HM, Levin BE. Regulation of hypothalamic neuronal sensing and food intake by ketone bodies and fatty acids. Diabetes 2014;63:1259-1269.
31. Patterson CM, Bouret SG, Dunn-Meynell AA, Levin BE. Three weeks of postweaning exercise in DIO rats produces prolonged increases in central leptin sensitivity and signaling. Am J Physiol Regul Integr Comp Physiol 2009;296: R537-R548.
32. Bouret SG, Gorski JN, Patterson CM, Chen S, Levin BE, Simerly RB. Hypothalamic neural projections are permanently disrupted in diet-induced obese rats. Cell Metab 2008;7:179-185.
33. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 1994;62:553-567.
34. Becskei C, Riediger T, Zünd D, Wookey P, Lutz TA. Immunohistochemical mapping of calcitonin receptors in the adult rat brain. Brain Res 2004;1030: 221-233.
35. Bates SH, Stearns WH, Dundon TA, et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 2003;421:856-859.
36. Buettner C, Pocai A, Muse ED, Etgen AM, Myers MG Jr, Rossetti L. Critical role of STAT3 in leptin's metabolic actions. Cell Metab 2006;4:49-60.
37. Braegger FE, Asarian L, Dahl K, Lutz TA, Boyle CN. The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping. Eur J Neurosci 2014;40:3055-3066.
38. Mietlicki-Baase EG, Hayes MR. Amylin activates distributed CNS nuclei to control energy balance. Physiol Behav 2014 Jan 28 [Epub ahead of print].
39. Febbraio MA. gp130 receptor ligands as potential therapeutic targets for obesity. J Clin Invest 2007;117:841-849.
40. Bjørbaek C, Uotani S, da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 1997;272:32686- 32695.
41. Banks WA, Kastin AJ. Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 1998;19:883-889.
42. Banks WA, Kastin AJ, Maness LM, Huang W, Jaspan JB. Permeability of the blood-brain barrier to amylin. Life Sci 1995;57:1993-2001.
43. Sharif A, Prevot V. Isolation and culture of human astrocytes. Methods Mol Biol 2012;814:137-151.
44. Kallen KJ. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta 2002;1592:323-343.
45. Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 2012;8:1254-1266.
46. White CA, Nicola NA. SOCS3: An essential physiological inhibitor of signaling by interleukin-6 and G-CSF family cytokines. JAKSTAT 2013;2:e25045.
47. Boyle CN, Lutz TA. Amylinergic control of food intake in lean and obese rodents. Physiol Behav 2011;105:129-137.
48. Ravussin E, Smith SR, Mitchell JA, et al. Enhanced weight loss with pramlintide/metreleptin: An integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring) 2009;17:1736-1743.
49. Seth R, Terry DE, Parrish B, Bhatt R, Overton JM. Amylin-leptin coadministration stimulates central histaminergic signaling in rats. Brain Res 2012; 1442:15-24.
50. Riediger T, Zuend D, Becskei C, Lutz TA. The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis. Am J Physiol Regul Integr Comp Physiol 2004;286:R114-R122.